Previous 10 |
Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal 2019 financial results after the stock market closes on February 20. The company will host a live webcast of its investor conference call in listen-only mode. Date: Wednesday, February 20, 2019 Time: 1:30 PM (Paci...
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Agilent Technologies, Inc. (NYSE:A), Xilinx, Inc. (NASDAQ:XLNX), Inter...
This article is about Agilent Technologies ( A ) and why it's a buy for the total return investor who also wants some dividend income. Agilent Technologies is one of the largest life sciences and chemical analysis testing products and services companies in the world. Agilent Technologies is a ...
Klövern has signed a rental contract with AP Pension regarding approximately 3 500 sq.m. of office space in the recently acquired property on Amerika Plads in Copenhagen. Moving-in is expected to be on 1 April 2019. A rental contract has also been signed with TUI Danmark regarding ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, loo...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Earnings season really starts to heat up after major banks knocked out some solid r...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
MAGE-A4 IHC 1F9 pharmDx is indicated as an aid in identifying patients with synovial sarcoma for whom TECELRA ® , a MAGE-A4-directed engineered T-Cell Receptor (TCR) therapy is being considered Agilent Technologies Inc. , (NYSE: A) today announced that it has received FDA a...
2024-08-01 15:15:03 ET William Blair analyst issues OUTPERFORM recommendation for A on August 1, 2024 01:31PM ET. The previous analyst recommendation was Outperform. A was trading at $143.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...